These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 2423256

  • 1. Inosine pranobex-BAN increases the resistance to the challenge with cells or cell-free fluid from Yoshida ascites tumor.
    Fimiani V, Cavallaro A, Falliti G, Amato A.
    Chemioterapia; 1986 Apr; 5(2):128-33. PubMed ID: 2423256
    [Abstract] [Full Text] [Related]

  • 2. Timunox increases resistance to the challenge with a low number of cells from Yoshida ascites tumor.
    Licastro G, Bottari C, Cavallaro A, Ainis T, Fimiani V.
    J Chemother; 1989 Jul; 1(4 Suppl):1172-3. PubMed ID: 16312820
    [No Abstract] [Full Text] [Related]

  • 3. Isoprinosine increases the antitumor action of interferon.
    Cerutti I, Chany C, Schlumberger JF.
    Cancer Treat Rep; 1978 Nov; 62(11):1971-4. PubMed ID: 83190
    [Abstract] [Full Text] [Related]

  • 4. Studies on the effect of cyclophosphamide on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Bhide S, Habs M, Reinhold H, Schmähl D.
    Arzneimittelforschung; 1979 Nov; 29(3):477-9. PubMed ID: 582732
    [Abstract] [Full Text] [Related]

  • 5. ACTH--inosine pranobex in the treatment of AIDS. Encouraging results.
    Addo E, McFarlane H, Parsad K.
    West Indian Med J; 1989 Sep; 38(3):142-7. PubMed ID: 2482585
    [Abstract] [Full Text] [Related]

  • 6. The influence of isoprinosine (ISO) on some cell immunity parameters in mice infected with influenza viruses and in mixed viral-bacterial infections. II. Phagocytosis and bactericidal activity of granulocytes.
    Kowalska M, Denys A, Szydłowska T, Białek J.
    Arch Immunol Ther Exp (Warsz); 1985 Sep; 33(6):741-53. PubMed ID: 2421685
    [Abstract] [Full Text] [Related]

  • 7. Inosine pranobex--is a single positive trial enough?
    Kweder SL, Schnur RA, Cooper EC.
    N Engl J Med; 1990 Jun 21; 322(25):1807-9. PubMed ID: 1693175
    [No Abstract] [Full Text] [Related]

  • 8. Comparative studies of inosine pranobex and acyclovir.
    Mindel A.
    Am J Med; 1988 Aug 29; 85(2A):7-9. PubMed ID: 2457315
    [Abstract] [Full Text] [Related]

  • 9. Effect of Inosiplex on BHK cells "in vitro".
    González-Diddi M, Rangel-Gutiérrez N, Tellez-Martínez J, Lonngi-Villanueva G, Hernández-Jauregui P.
    Arch Invest Med (Mex); 1980 Aug 29; 11(2):249-65. PubMed ID: 6158923
    [Abstract] [Full Text] [Related]

  • 10. [Isoprinosine].
    Vâţă A.
    Rev Med Chir Soc Med Nat Iasi; 1982 Aug 29; 86(3):507-9. PubMed ID: 6189169
    [No Abstract] [Full Text] [Related]

  • 11. [Therapeutic experiences with the immunostimulator inosine pranobex].
    Darlath W, Wybran J.
    Fortschr Med; 1984 Oct 04; 102(37):932-4. PubMed ID: 6209193
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Randomised, double blind, placebo controlled trial of inosine pranobex in rheumatoid arthritis.
    Brzeski M, Madhok R, Hunter JA, Capell HA.
    Ann Rheum Dis; 1990 May 04; 49(5):293-5. PubMed ID: 1693065
    [Abstract] [Full Text] [Related]

  • 16. Immune response in thermally injured guinea-pigs treated with methisoprinol.
    Castelli A, Sbano E, Fimiani M, Francini G, Andreassi L, Gennari C.
    Int J Tissue React; 1984 May 04; 6(2):123-6. PubMed ID: 6203860
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.